Cargando…
Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen
Exposure to protein allergen epicutaneously, inducing a Th2-dominant immune response, sensitizes the host to the development of atopic disease. Antigen-driven bystander effect demonstrates that polarized T cells could instruct naïve T cells to differentiate into T cells with similar phenotype. In th...
Autores principales: | Wang, Li-Fang, Chen, Jau-Shiuh, Hsu, Chih-Jung, Liu, Ching-Yi, Yu, Jhang-Sian, Miaw, Shi-Chuen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656495/ https://www.ncbi.nlm.nih.gov/pubmed/19272128 http://dx.doi.org/10.1186/1423-0127-16-28 |
Ejemplares similares
-
Concurrent exposure to a dectin-1 agonist suppresses the Th2 response to epicutaneously introduced antigen in mice
por: Lin, Jing-Yi, et al.
Publicado: (2013) -
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017) -
Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021) -
Activin A Inhibits Antigen-Induced Allergy in Murine Epicutaneous Sensitization
por: Kypriotou, Magdalini, et al.
Publicado: (2013) -
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015)